Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

The Risks of Outsourcing Medical Billing and the Importance of State-Law Compliance

Client Alert

Offshoring medical billing and other administrative functions can reduce costs, but it also raises significant compliance, operational, and contractual risks. Although HIPAA does not explicitly prohibit protected health information from being accessed or stored outside the United States, healthcare providers and their vendors remain responsible for safeguarding patient information and complying with state-specific restrictions that may limit or prohibit offshore subcontracting. 

For healthcare organizations, outsourcing billing can create exposure far beyond routine vendor-management issues. If an offshore billing company mishandles protected health information, submits inaccurate claims, or fails to follow applicable payer requirements, the provider, not just the vendor, may face delayed reimbursement, audit scrutiny, breach-response costs, contractual disputes, and reputational harm. 

HIPAA considerations

HIPAA protects protected health information (PHI), including individually identifiable health information maintained or transmitted by covered entities and business associates. Vendors that create, receive, maintain, or transmit PHI on behalf of a covered entity generally qualify as business associates and must comply with HIPAA’s applicable privacy and security obligations. 

At a minimum, organizations should confirm that outsourcing arrangements address:

  • appropriate access controls and role-based permissions;
  • encryption and other reasonable safeguards for PHI;
  • workforce training and documented compliance policies;
  • a compliant Business Associate Agreement (BAA);
  • audit rights, monitoring, and recordkeeping; and
  • clear breach reporting and notification procedures.

State-law and program requirements

HIPAA is only part of the analysis. State Medicaid rules, managed care agreements, provider manuals, executive orders, and other state authorities may impose additional restrictions on offshore subcontracting. In some jurisdictions, these restrictions can require that certain services be performed in the United States or that patient data remain within the country. As a result, a provider may be compliant with HIPAA yet still violate contract or state-specific requirements. 

This risk is especially important because enforcing contractual and privacy obligations against an offshore vendor may be incredibly difficult. When a foreign subcontractor experiences a breach or other compliance failure, the healthcare provider often bears the immediate burden of investigation, remediation, patient notification, and regulator response. 

Practical takeaways

Before outsourcing billing or related administrative functions overseas, providers should:

  • review state statutes, administrative codes, Medicaid guidance, and managed care contract requirements that may apply to the services at issue;
  • confirm whether any payer or provider agreement restricts subcontracting or offshore access to PHI;
  • conduct diligence on the vendor’s technical, administrative, and legal safeguards;
  • negotiate a BAA and service agreement with audit rights, indemnification, reporting obligations, and clear data-security requirements; and
  • implement ongoing monitoring to verify compliance after the arrangement begins.

For questions regarding the individualized risk requirements or assistance with compliance and implementation, please contact Amanda Waesch at alwaesch@bmdllc.com


Valley National Bank/Trulieve Loan: A Big Step Out of the Shadows

In a late December press release, Trulieve announced that it had secured a $71.5 million commercial bank loan. In addition to the amount of the loan, which may be the largest commercial bank loan to date to a cannabis company, the release prominently identified Valley Bank and featured both a quote from Valley’s Senior Vice President, John Myers, and a description of the Bank’s service platform and commitment to the cannabis industry.

The End of Non-Competes? The Impact It Will Have on the Healthcare Industry

On January 5, 2023, the Federal Trade Commission (“FTC”) announced a proposed rule that, if enacted, will ban employers from entering into non-compete clauses with workers (the “Rule”), and the Rule would void existing non-compete agreements. In their Notice, the FTC stated that if the Rule were to go into effect, they estimate the overall earnings of employees in the United States could increase by $250 billion to $296 billion per year. The Rule would also require employers to rescind non-competes that they had already entered into with their workers. For purposes of the Rule, the FTC has defined “worker” to also include any employees, interns, volunteers, and contractors.”

2022 Healthcare Recap and 2023 Healthcare Check-Up

As the country begins to return to a new “normal” following the COVID-19 pandemic, there are many healthcare rules changing on both the federal and state levels as a result. Thus, it is important for healthcare providers and their employers to be aware of these changing rules, and any implications they may have on their practice. Look back on healthcare in 2022 and find a checklist for 2023.

Direct Support Professional Retention Payments

On December 15, the Ohio Senate and House passed House Bill 45, which authorizes the Department of Developmental Disabilities (DODD), in conjunction with the county boards of developmental disabilities, to launch their initiative to issue retention payments to Direct Support Professionals (DSPs). These retention payments will be distributed quarterly to participating home and community-based waiver providers to address the workforce crisis in the direct provider sector. Governor DeWine needs to sign the Bill to begin the payments, but he is expected to do so by the end of 2022.

Real Estate Investors Position for 2023 Opportunities

Real estate investors weathered another year in a post-pandemic world, with the year closing with yet another interest rate increase coupled with both uncertainty and heightened interest carrying into 2023. Just last Wednesday, the Federal Reserve raised its benchmark interest rate 0.50 percentage points, shifting the target range to 4.25% to 4.50%. The new level is the highest the fed funds rate has been since December 2007 and marks the seventh rate hike this year. So what does this mean to investors, brokers, lenders, and others in the real estate world? Read a few perspectives below from stakeholders familiar with our BMD clients and the markets in which they do business.